HBM Healthcare Investments (Cayman) Ltd. 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:15 pm Unchanged | 2024-12-31 | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 1,041,669 4.500% | 0 (Unchanged) | Filing |
| 2024-11-13 4:18 pm Purchase | 2024-09-30 | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 1,041,669 9.700% | 191,776 (+22.56%) | Filing |
| 2024-04-29 4:05 pm Purchase | 2024-04-17 | 13G | Benitec Biopharma Inc. BNTC | HBM Healthcare Investments (Cayman) Ltd. | 849,893 9.990% | 849,893 (New Position) | Filing |